Sector dividends Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
20:59:50 12/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 302.27 USD | +0.10% |
|
+3.99% | +51.24% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.45% | 1.59% | 20.5x | 4.83x | 7.3x | 14.66x | 16.31x | 70.65B | ||
| 0.05% | 0.1% | 27.57x | 5.25x | 7.54x | 23.67x | 24.06x | 51.22B | ||
| 0.97% | 1.12% | 33.47x | 4.49x | 6.01x | 18.01x | 25.22x | 48.04B | ||
| -.--% | -.--% | 33.77x | 6.27x | 3.27x | 14.13x | 20.84x | 43.16B | ||
| -.--% | -.--% | -20.11x | 20.82x | 203.7x | -21.41x | -20.44x | 41.57B | ||
| -.--% | -.--% | 46.41x | 7.49x | 5.27x | 28.96x | 33.26x | 39.84B | ||
| 0.42% | 0.43% | 27.3x | 2.2x | 7.78x | 20.18x | 23.58x | 30.87B | ||
| -.--% | -.--% | 31.79x | 3.34x | 6.78x | 17.59x | 21.09x | 27.53B | ||
| -.--% | -.--% | -14.56x | 1.23x | 5.85x | -7.07x | -5.62x | 24.08B | ||
| -.--% | -.--% | -60.3x | 31.65x | 11.61x | -58.43x | -67.29x | 21.52B | ||
| -.--% | -.--% | 30.56x | 3.64x | 5.68x | 19.04x | 21.51x | 22.2B | ||
| -.--% | -.--% | 35.26x | 26.28x | 5.79x | 26.33x | 27.55x | 17.31B | ||
| 0.34% | 0.2% | 43.85x | 10.74x | 16.27x | 33.43x | 35.92x | 15.37B | ||
| 1.03% | 1.17% | 25.89x | 2.85x | 2.25x | 9.65x | 14.95x | 15.06B | ||
| -.--% | -.--% | 18.51x | 5.69x | 5.51x | 12.9x | 13.66x | 14.82B | ||
| -.--% | -.--% | 72.97x | 4.67x | 4.21x | 16.16x | 20.07x | 14.41B | ||
| -.--% | -.--% | -14.99x | 51.25x | 3372.84x | -17.28x | -14.71x | 13.7B | ||
| -.--% | -.--% | 978.38x | 15.87x | 34.03x | 587.87x | -220.21x | 13.7B | ||
| Average | 0.24% | 0.26% | 73.13x | 11.59x | 206.21x | 41.02x | -1.68x | 29.17B | |
| Weighted average by Cap. | 0.35% | 0.39% | 45.49x | 9.42x | 110.75x | 25.61x | 7.05x |
Select your edition
All financial news and data tailored to specific country editions
















